C4 Therapeutics (CCCC) EBITDA Margin Growth (3y) (2022 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -40,178.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 530.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -932.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,003.00 |
| 10 | C4 Therapeutics | 561.03 Mn | 325.36 Mn | - | 46,638.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46,638.00 |
| Dec 31, 2025 | 107,156.00 |
| Sep 30, 2025 | 20,004.00 |
| Jun 30, 2025 | -19,885.00 |
| Mar 31, 2025 | 8,688.00 |
| Dec 31, 2024 | -59,451.00 |
| Sep 30, 2024 | 13,666.00 |
| Jun 30, 2024 | 8,254.00 |
| Mar 31, 2024 | -65,772.00 |
| Dec 31, 2023 | -77,818.00 |
| Sep 30, 2023 | 2,204.00 |
| Jun 30, 2023 | -121,066.00 |
| Mar 31, 2023 | -70,613.00 |
| Dec 31, 2022 | -113,629.00 |
| Sep 30, 2022 | -29,734.00 |